195 related articles for article (PubMed ID: 6408181)
21. Cathepsin H: an endoaminopeptidase from rat liver lysosomes.
Kirschke H; Langner J; Wiederanders B; Ansorge S; Bohley P; Hanson H
Acta Biol Med Ger; 1977; 36(2):185-99. PubMed ID: 906730
[TBL] [Abstract][Full Text] [Related]
22. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
Marder SR; Chenoweth DE; Goldstein IM; Perez HD
J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
[TBL] [Abstract][Full Text] [Related]
23. The fifth component of complement is not required for the clearance of Staphylococcus aureus.
Toews GB; Pierce AK
Am Rev Respir Dis; 1984 Apr; 129(4):597-601. PubMed ID: 6712000
[TBL] [Abstract][Full Text] [Related]
24. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
Perez HD; Hooper C; Volanakis J; Ueda A
J Immunol; 1987 Jul; 139(2):484-9. PubMed ID: 3648093
[TBL] [Abstract][Full Text] [Related]
25. Specific inhibition of the polymorphonuclear leukocyte chemotactic response to hydroxy-fatty acid metabolites of arachidonic acid by methyl ester derivatives.
Goetzl EJ; Valone FH; Reinhold VN; Gorman RR
J Clin Invest; 1979 Jun; 63(6):1181-6. PubMed ID: 447841
[TBL] [Abstract][Full Text] [Related]
26. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
Hammer CH; Hänsch G; Gresham HD; Shin ML
J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
[TBL] [Abstract][Full Text] [Related]
27. Complement activation by nylon- and polypropylene-looped prosthetic intraocular lenses.
Tuberville AW; Galin MA; Perez HD; Banda D; Ong R; Goldstein IM
Invest Ophthalmol Vis Sci; 1982 Jun; 22(6):727-33. PubMed ID: 7076418
[TBL] [Abstract][Full Text] [Related]
28. Lipopolysaccharide-induced pulmonary vascular sequestration of polymorphonuclear leukocytes is complement independent.
Cardozo C; Edelman J; Jagirdar J; Lesser M
Am Rev Respir Dis; 1991 Jul; 144(1):173-8. PubMed ID: 2064126
[TBL] [Abstract][Full Text] [Related]
29. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
[TBL] [Abstract][Full Text] [Related]
30. Turnover and distribution of cathepsin G in the rat.
Björk P; Luts A; Sundler F; Ohlsson K
Scand J Clin Lab Invest; 1993 Oct; 53(6):539-46. PubMed ID: 8265998
[TBL] [Abstract][Full Text] [Related]
31. Biologically active peptides derived from the fifth component of complement.
Goldstein IM; Perez HD
Prog Hemost Thromb; 1980; 5():41-79. PubMed ID: 6999532
[No Abstract] [Full Text] [Related]
32. Lysosomal peptidases and glycosidases in rheumatoid arthritis.
Sohar N; Hammer H; Sohar I
Biol Chem; 2002 May; 383(5):865-9. PubMed ID: 12108554
[TBL] [Abstract][Full Text] [Related]
33. Cathepsin B-like activity in viable tumor cells isolated from rodent tumors.
Ryan RE; Crissman JD; Honn KV; Sloane BF
Cancer Res; 1985 Aug; 45(8):3636-41. PubMed ID: 3893687
[TBL] [Abstract][Full Text] [Related]
34. The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs).
Goetzl EJ; Pickett WC
J Immunol; 1980 Oct; 125(4):1789-91. PubMed ID: 7410854
[TBL] [Abstract][Full Text] [Related]
35. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
Gibson TL; Cohen P
Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
[TBL] [Abstract][Full Text] [Related]
36. Generation of a fibroblast chemotactic factor in serum by activation of complement.
Postlethwaite AE; Snyderman R; Kang AH
J Clin Invest; 1979 Nov; 64(5):1379-85. PubMed ID: 91624
[TBL] [Abstract][Full Text] [Related]
37. C5 fragments: are they important in polymorphonuclear leucocyte diapedesis?
Russo M; Arruda AM; Jancar S
Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):361-9. PubMed ID: 3738213
[TBL] [Abstract][Full Text] [Related]
38. Identification and possible regulation of muscle cell lysosomal protease activity by exogenous protease inhibitors.
Stauber WT; Gauthier F; Ong SH
Acta Biol Med Ger; 1981; 40(10-11):1317-22. PubMed ID: 7043996
[TBL] [Abstract][Full Text] [Related]
39. Role of 5-lipoxygenase products in the local accumulation of neutrophils in dermal inflammation in the rabbit.
Marleau S; Fruteau de Laclos B; Sanchez AB; Poubelle PE; Borgeat P
J Immunol; 1999 Sep; 163(6):3449-58. PubMed ID: 10477617
[TBL] [Abstract][Full Text] [Related]
40. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils.
Ward PA; Hill JH
J Immunol; 1970 Mar; 104(3):535-43. PubMed ID: 4985169
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
